ライフサイエンスコーパス: interventional

1 hirty-five papers reporting on 22 studies (9 interventional,13 observational; total 13,737 participan

2 The 149 trials included 101 non-interventional, 33 interventional, and 15 vaccine trials

3 Study designs included observational (85%), interventional (7%), qualitative (5%), and mixed methods

4 ons, a lymphatic pathologic abnormality, and interventional access routes were identified with an acc

5 As a result of this safety signal, Vascular InterVentional Advances Physicians (VIVA), a not-for-pro

6 mal waist circumference were included in the interventional analysis.

7 the choice of imaging techniques as well as interventional and antibiotic therapy in the context of

8 Cognitive function is related to interventional and non-interventional variables.

9 mmatory cytokines and biomarkers between the interventional and observational cohorts.

10 All interventional and observational studies were reviewed,

11 observational trial bridges the gap between interventional and retrospective RWD collection methods.

12 9 trials included 101 non-interventional, 33 interventional, and 15 vaccine trials.

13 orty patients meeting all clinical, imaging, interventional, and laboratory inclusion criteria could

14 Supporting the genetic approach, an interventional approach using ultrasound-targeted microb

15 Different interventional approaches are available for biloma drain

16 agnostic tool to an adjunctive tool to guide interventional approaches for treatment of VT.

17 , diagnostics, precision medicine, and other interventional approaches targeting epigenetic fingerpri

18 comprehensive and fast assessment of future interventional approaches.

19 udinal studies with large sample size and an interventional arm are needed to substantiate the role o

20 Design: Prospective interventional bicentric cohort study with infant enroll

21 The interventional cardiologist was blinded to the DE-CMR re

22 s for optimal performance for the practicing interventional cardiologist.

23 Interventional cardiologists are occupationally exposed

24 Interventional cardiologists at 2 cardiac catheterizatio

25 Interventional cardiologists consider both clinical and

26 d was widely expected to fulfil the dream of interventional cardiologists of a transient scaffold tha

27 ng-term device-related complications (14.1%; interventional cardiologists, 15.3%; general cardiologis

28 complications (electrophysiologists, 16.7%; interventional cardiologists, 17.0%; general cardiologis

29 n formulated by a multidisciplinary group of interventional cardiologists, electrophysiologists, and

30 exclusive categories: electrophysiologists, interventional cardiologists, general cardiologists, tho

31 linary approach that combines expertise from interventional cardiologists, heart failure specialists,

32 ice-related complications (relative risk for interventional cardiologists: 1.16 [95% CI, 1.08-1.25];

33 l atherectomy (RA) is an established tool in interventional cardiology for treatment of calcified cor

34 e SYNTAX score might be considered useful in interventional cardiology.

35 alty (electrophysiology=2; heart failure=11; interventional cardiology=8; P=0.020) and multiregional

36 an opportunity to improve access to complex interventional care without sacrificing quality.

37 pancreatitis, requiring advanced medical and interventional care.

38 A retrospective, interventional case series in which 81 eyes underwent th

39 he purpose of this single-center prospective interventional case series was to evaluate the feasibili

40 This study was a retrospective, consecutive, interventional case series.

41 Design: Prospective, interventional case series.

42 Interventional case series.

43 Retrospective analysis of a consecutive, interventional case series.

44 Retrospective, nonrandomized, interventional case series.

45 Prospective, noncomparative, consecutive interventional case series.

46 Prospective, noncomparative, interventional case series.

47 niques to quantify cerebral perfusion during interventional cerebral angiography.

48 tacts (HHCs) to inform the development of an interventional clinical trial.

49 Here, we review currently registered interventional clinical trials for the treatment and pre

50 ClinicalTrials.gov, we identified all active interventional clinical trials in diabetic eye disease s

51 se modalities in natural history studies and interventional clinical trials.

52 Stratification of the interventional cohort by mesenchymal stem/stromal cell d

53 Here, we use a human interventional cohort study (ACTRN12615001302549) to und

54 This prospective interventional cohort study (NCT02267174) was conducted

55 Retrospective interventional cohort.

56 Setting: Retrospective, interventional comparative case series.

57 Prospective consecutive, interventional, comparative case series.

58 Despite the increasing use and success of interventional coronary reperfusion strategies, morbidit

59 We therefore propose that the use of an interventional cross-circulation platform could enable r

60 eet transplantation criteria by utilizing an interventional cross-circulation platform in a clinicall

61 Methods: First, an interventional crossover trial in adult subjects with AR

62 image registration of (68)Ga-PSMA PET/CT and interventional CT.

63 Interventional data are high quality but narrowly focuse

64 t (ROI) selection on SUVR effect sizes using interventional data from the ongoing phase 1b PRIME stud

65 Using a randomized interventional design, we investigated postmenopausal ov

66 Research using large longitudinal interventional designs across the range of allergic cond

67 vessel pathways and accurate placement of an interventional device, which has resulted in increased r

68 Two interventional devices using pharmacomechanical means to

69 Nine metallic interventional devices were found to be intrinsically sa

70 An interventional diagnostic procedure with reference invas

71 ted the feasibility and effectiveness of pre-interventional DR for preventing AKI in patients undergo

72 tional study included 30 eyes, and the pilot interventional feasibility study was performed on 8 eyes

73 g occurred in 3/28 patients (10,7%) and post-interventional fever in one patient (3,6%).

74 nd Staff who perform fluoroscopically guided interventional (FGI) procedures are among the most highl

75 d, and 178 studies (165 observational and 13 interventional) from 33 countries were included.

76 st 2009 and December 2016 from the Melbourne Interventional Group registry undergoing PCI with pre-pr

77 TAs and alcohol consumption in Scotland (the interventional group) and England and Wales (the control

78 with a total of 400 patients (control group:interventional group, 200:200) to determine the effect o

79 or interventional therapy and 80% in the non-interventional group.

80 e 152 321 (43.3%) of 351 710 patients in the interventional groups in London and Bradford.

81 group or to one of four targeted screening (interventional) groups: standard (ie, hospital-based) ca

82 Prospective interventional internal-control cohort study in which st

83 ity communication and urgent mobilization of interventional laboratory resources.

84 occurred in 129 of 131 patients (98.5%) with interventional management and in 118 of 125 (94.4%) with

85 e management is an acceptable alternative to interventional management for uncomplicated, moderate-to

86 Surgical or interventional management is indicated in symptomatic ca

87 Patients were randomly assigned to immediate interventional management of the pneumothorax (intervent

88 spontaneous pneumothorax was noninferior to interventional management, with a lower risk of serious

89 verse events or pneumothorax recurrence than interventional management.

90 be a valuable resource for the surgical and interventional medical communities.

91 r capita) effective dose from diagnostic and interventional medical procedures was estimated to have

92 ified program directors from 14 surgical and interventional medical specialties.

93 Retrospective observational, non-interventional, monocentric study of a cohort of 214 ICU

94 In a prospective, open-label, interventional multi-center study, we examined the safet

95 This prospective, interventional, multicenter clinical trial assessed the

96 A retrospective, interventional, multicenter study of all patients with c

97 n = 28), case series (n = 8), single-patient interventional (n = 13), pretest and posttest (n = 9), r

98 = 106) were randomly assigned to either the interventional (n = 48) or placebo (n = 49) group; 9 inf

99 rs, including five neuroradiologists and two interventional neuroradiology fellows, independently rev

100 This was a prospective interventional non-randomized series of cases.

101 A prospective, interventional, nonrandomized study.

102 Interventional/Observational Procedure: Color fundus and

103 lusion and exclusion criteria of prospective interventional oligometastatic disease clinical trials.

104 Both interventional oncology and immuno-oncology can potentia

105 Interventional oncology is a subspecialty field of inter

106 Furthermore, the review addresses interventional opportunities and questions to be answere

107 f significant interest, potentially offering interventional opportunities in relation to synthetic le

108 Interventional or observational studies containing origi

109 The primary endpoint of the interventional part was change in urinary [tissue inhibi

110 In the interventional part, patients were randomized to receive

111 8.0) and re-hospitalization (9 [7.3%] of 123 interventional participants versus 25 [20.5%] of 122 con

112 on in the risk of relapse (26 [21.7%] of 120 interventional participants versus 40 [34.2%] of 117 con

113 Interventional pharmacology is one of medicine's most po

114 thresholds for PCI are adhered to in routine interventional practice and whether adherence to these t

115 cardiovascular deaths were unrelated to the interventional procedure (335, 72%).

116 n of relevant patient cohorts, and optimized interventional procedures have likely contributed to the

117 ly registered hybrid images, which could aid interventional procedures involving radionuclides.

118 llow-up for fluoroscopically guided vascular interventional procedures over 8 years.

119 ized real-time, objective assessments of the interventional procedures performed to treat vasospasm.

120 eep learning could be useful in image-guided interventional procedures such as radiation therapy and

121 se condition at admission and received fewer interventional procedures with a greater odds of inpatie

122 nage only; B2: pharmacologic management; B3: interventional procedures).

123 ormed after coronary angiography, subsequent interventional procedures, and intravenous US.

124 ormed after coronary angiography, subsequent interventional procedures, and intravenous US.

125 ormed after coronary angiography, subsequent interventional procedures, and intravenous US.

126 proaches, ranging from prolonged drainage to interventional procedures, but the spectrum of clinical

127 ccess is the default strategy for large-bore interventional procedures, including temporary mechanica

128 ted by spontaneous, surgical or percutaneous interventional procedures.

129 y site and degrade to reduce the duration of interventional procedures.

130 thrombosis, in light of comorbidities and/or interventional procedures.

131 idizes the power of molecularly based master interventional protocols with the breadth of real-world

132 equent generations that can be exploited for interventional purposes.

133 006, an estimated 377 million diagnostic and interventional radiologic examinations were performed.

134 aneurysms and their appropriate treatment by interventional radiological methods in this article.

135 Over the past few years, interventional radiological treatment has evolved and ta

136 morrhage and vascular anatomy that helps the interventional radiologist in pre-procedural planning.

137 internal cemented screws as performed by the interventional radiologist is a safe nonsurgical treatme

138 United States were surveyed by emailing all interventional radiologist members of the Society of Int

139 ability, image quality, and artifacts by two interventional radiologists blinded to each other.

140 ed surgery provides surgical oncologists and interventional radiologists both macroscopic and microsc

141 ylactic image-guided procedures performed by interventional radiologists for impending pathologic fra

142 Materials and Methods A total of 3889 interventional radiologists from academic and private pr

143 Two interventional radiologists independently categorized ca

144 Two interventional radiologists performed detailed radiologi

145 ch, including gastroenterologists, surgeons, interventional radiologists, and specialists in critical

146 quire close collaboration between engineers, interventional radiologists, medical oncologists, and im

147 hout intensive care unit (46.9% vs 22.4%) or interventional radiology (22.8% vs 12.8%).

148 The risk of infection from interventional radiology (IR) procedures is not well doc

149 adiation risk in patients undergoing cardiac interventional radiology (IR) procedures.

150 o hemostasis, as a complement to an existing interventional radiology (IR) service.

151 Interventional radiology (IR) team was successful with t

152 espite increased use of moderate sedation in interventional radiology (IR), patient reactions to mode

153 with the necessary endoscopic expertise and interventional radiology and surgical backup.

154 tic system (CLS) are increasingly treated by interventional radiology approaches.

155 ients (12.2%) had a complication (Society of Interventional Radiology class A, two of 41 [4.9%]; clas

156 surgeons should be aware of the support that interventional radiology could provide in the case of ia

157 This paper focuses on the role of interventional radiology embolisations in a series of pa

158 We also consider the fundamental role of interventional radiology in the treatment of pseudotumor

159 Imaging and interventional radiology management are described in det

160 and urgent surgical treatment combined with interventional radiology played a decisive role in the f

161 tive patients with COVID-19 who underwent 21 interventional radiology procedures between March 13, 20

162 the United States, respiratory compromise in interventional radiology procedures with moderate sedati

163 derwent SARS CoV-2 testing before surgeries, interventional radiology procedures, and endoscopy.

164 AP implantation procedure carried out in the interventional radiology suite provides an advantage in

165 -time fluoroscopic and nuclear images in the interventional radiology suite.

166 lications following CVAP implantation in the interventional radiology suite.

167 entional oncology is a subspecialty field of interventional radiology that addresses the diagnosis an

168 paper aims to describe our experience in an interventional radiology unit in a hospital in Spain tha

169 ization is a common nonsurgical procedure in interventional radiology used for the deliberate occlusi

170 tional radiologist members of the Society of Interventional Radiology, including attending-level phys

171 representatives of cardiovascular medicine, interventional radiology, vascular medicine, and vascula

172 Nearly half of unplanned interventional radiology-related readmissions are potent

173 Interventional radiology-related readmissions were categ

174 Of unplanned interventional radiology-related readmissions, 16% (nine

175 planned causes as related to or unrelated to interventional radiology.

176 readmissions (57 of 78; 73%) were related to interventional radiology.

177 This prospective, interventional, randomized clinical study was done at Al

178 It is a prospective, interventional, randomized, and crossover study in patie

179 clinical platform before performing clinical interventional research on novel therapeutic agents in h

180 Perioperative interventional research to reduce the anticholinergic ex

181 ng deteriorating patients and an appropriate interventional response (eg, rapid response teams).

182 a meta-analysis with meta-regression of 603 interventional rodent studies (10,364 animals) in NAFLD

183 Retrospective comparative interventional series.

184 The overall POC interventional sessions (2.0 +/- 0.65 vs. 2.9 +/- 1.21 s

185 also improves procedural planning and allows interventional simulation.

186 he pathway to the final pathogenic and hence interventional step, and problems with interpreting cros

187 ommensal strains, opening up new avenues for interventional strategies against this pathogen.

188 ment-is supporting the identification of new interventional strategies against tuberculosis thanks to

189 Our findings suggest that different interventional strategies are needed to improve vitamin

190 cal in vivo testing of novel drugs and other interventional strategies for clinical translation, plus

191 APOE, which could aid potential therapeutic/interventional strategies in the detection and preventio

192 consultations regarding the pathogenesis and interventional strategies of neurodegenerative disease.

193 Our discoveries may uncover new potential interventional strategies that block EBV and KSHV infect

194 that research must focus on the discovery of interventional strategies that will permanently reduce t

195 vulnerable patients and warrants supportive interventional strategies to facilitate their RTW.

196 e need for the development and evaluation of interventional strategies to mitigate the potential harm

197 The most frequently employed interventional strategies were education (78.9%), enable

198 ne regulatory mechanisms and for testing new interventional strategies.

199 on strict inclusion/exclusion criteria, non-interventional studies (NISs) might provide additional i

200 nockout studies in mice, as well as clinical interventional studies and advanced mRNA sequencing tech

201 Additional high-quality interventional studies are needed to further evaluate th

202 psia, and the need for an increased focus on interventional studies during the asymptomatic phase to

203 rpowered to detect CVD end points, and small interventional studies examining surrogate CVD end point

204 ransgenic lineage tracing mice, and clinical interventional studies have shown that both innate and a

205 servational studies in humans, findings from interventional studies in which periodontal therapy fail

206 cal phase of dementia, and the evidence from interventional studies is not conclusive.

207 The search included observational and interventional studies of healthy children aged 1-18 y t

208 Interventional studies probed the role of crystal-induce

209 analysis assessing case-control, cohort, and interventional studies reporting on the safety (primary

210 abetes has been defined by observational and interventional studies since publication of the 2009 rep

211 All observational and interventional studies that measured post-operative tric

212 se findings provide the rationale for future interventional studies to explore new blood glucose mana

213 benefits of probiotics has progressed beyond interventional studies to identifying the underlying mol

214 Here we summarize experimental and human interventional studies which investigated the antithromb

215 uded only systematic reviews, meta-analyses, interventional studies, and observational studies that h

216 from surveillance studies, registry data or interventional studies, in which specific inclusion and

217 nt, Development and Evaluation framework for interventional studies.

218 itiation, that should be further examined in interventional studies.

219 nts is less certain because of a scarcity of interventional studies.

220 not supported by small-scale and short-term interventional studies.

221 there is a need for further longitudinal and interventional studies.

222 We performed a prospective interventional study assessing symptoms (Patient Assessm

223 This study was a single-center, interventional study comparing rates of fascial redehisc

224 B-GAP was an interventional study done in the city of Bulawayo and th

225 This observational, prospective, non-interventional study enrolled patients aged >=18 years s

226 ted a prospective nonrandomized, nonblinded, interventional study in 3 hospitals in Israel, Switzerla

227 nt Evaluation) is a global, prospective, non-interventional study in the real-world setting, sponsore

228 Only one HIV prevention interventional study in this population was identified,

229 ) imaging to detect cancer in a prospective, interventional study of 10,006 women not previously know

230 We provide the results of the first interventional study of cytomegalovirus (CMV)-specific i

231 In this pilot interventional study performed at the Veterans Affairs P

232 Interventional study to evaluate the etiology, visual ou

233 This prospective interventional study was conducted on 20 eyes of 20 pati

234 A multicenter consecutive case series non-interventional study was performed.

235 In a pilot interventional study we found that switching from a high

236 In a prospective interventional study, freshly collected autologous adipo

237 In this prospective interventional study, we offered 2 doses of VZV vaccine

238 performed to model the power in a simulated interventional study.

239 A) assessor-masked, multicenter, randomized, interventional study.

240 Prospective interventional study.

241 Prospective, crossover, nonrandomized interventional study.

242 er, prospective, open label, noncomparative, interventional study.

243 ad been integrated in a score to predict the interventional success.

244 evaluate scholarship in multi-institutional interventional surgical education trials.

245 s underscore immune homeostasis as a pivotal interventional target against clock-related disorders.

246 ial to identify novel prediction markers and interventional targets for cancer immunoprevention.See r

247 herapy-induced OM and the development of new interventional targets for the management of this severe

248 e signatures might contribute to identifying interventional targets to be modulated prior to vaccinat

249 will facilitate cell-based mapping of novel interventional targets with direct functional relevance

250 phenotyping, mechanistic understanding, and interventional therapeutic capability; however, with ove

251 udication of risks and benefits of available interventional therapies for PE follows.

252 enable to specific preventive strategies and interventional therapies related to cardiovascular disea

253 c spasms will likely provide new targets for interventional therapies.

254 recovery and are suitable and susceptible to interventional therapies.

255 llocated to medical management compared with interventional therapy (283 vs 369; 58.97 vs 78.73 per 1

256 ent-years) than with medical management with interventional therapy (41 of 116, 12.32 per 100 patient

257 ent alone (n=110) or medical management plus interventional therapy (n=116).

258 and six, to medical management alone or with interventional therapy (neurosurgery, embolisation, or s

259 owed a complete resolution rate of 78.3% for interventional therapy and 80% in the non-interventional

260 to clarify the current state of endovascular interventional therapy for acute PE and to provide consi

261 edical management alone remained superior to interventional therapy for the prevention of death or sy

262 the medical management group and four in the interventional therapy group (two attributed to interven

263 to the combination of medical management and interventional therapy in preventing symptomatic stroke

264 ut does not change in response to medical or interventional therapy over 3 months.

265 venous malformation, who had never undergone interventional therapy, and were considered by participa

266 Rotational atherectomy (RA) is an important interventional tool for heavily calcified coronary lesio

267 Standard Protocol Items: Recommendations for Interventional Trails (SPIRIT).

268 isk of access site complication resulting in interventional treatment (1.3% vs 0.8%; absolute differe

269 Pulmonary vein isolation (PVI) as interventional treatment for atrial fibrillation (AF) ai

270 have shown that early recognition, emergency interventional treatment of acute ischemic stroke, and t

271 the use of new combined pharmacological and interventional treatment strategies has led to a remarka

272 Interventional treatments for pain or cholestasis should

273 e to discuss the current knowledge regarding interventional treatments for patients with portal hyper

274 osis (first section); we reviewed the use of interventional treatments in patients with hepatic vein

275 ients require reperfusion by thrombolysis or interventional treatments; those patients are hemodynami

276 subject selection and sample size in future interventional trial design.

277 We performed a single-arm interventional trial measuring NAb and total antibody ti

278 This single-arm, interventional trial took place at the Johns Hopkins Sid

279 trolled matched-triplet crossover open-label interventional trial, participants were matched into tri

280 The causality link could be addressed in an interventional trial.

281 opathy that can be used in the design of new interventional trials and for personalized approaches to

282 advance, answers questions that traditional interventional trials generally do not address, and seam

283 not address, and seamlessly integrates with interventional trials in both diagnostic and therapeutic

284 sign of natural history studies and upcoming interventional trials in sarcoglycanopathies.

285 haracteristics and rates of noncompliance in interventional trials involving common causes of blindne

286 7, when the mean 1-year publication rate for interventional trials rose from 12.7% to 19.6% (p = 0.04

287 ssociation, and summarize results of initial interventional trials that examined the effects of CMV p

288 These results highlight the need for interventional trials to assess the potential for vitami

289 Standard Protocol Items: Recommendations for Interventional Trials) guideline authors (n = 16), pharm

290 Standard Protocol Items: Recommendations for Interventional Trials-Artificial Intelligence) extension

291 Standard Protocol Items: Recommendations for Interventional Trials-Artificial Intelligence).

292 and inform the design and interpretation of interventional trials.

293 ient selection or as an outcome parameter in interventional trials.

294 d categories: prospective cohort studies and interventional trials.

295 amilies and help define endpoints for future interventional trials.

296 n outcomes and stratification of patients in interventional trials.

297 e their suitability as surrogate markers for interventional trials.

298 educe the required sample size for simulated interventional trials.

299 derwent a transthoracic needle biopsy at the interventional unit from January 1, 2013 to June 30, 201

300 unction is related to interventional and non-interventional variables.